Home Health Care Regeneron eyes future growth

Regeneron eyes future growth


Regeneron Pharmaceuticals Inc., based in Tarrytown, anticipates FDA approval of its second drug, EYLEA, in August, and expects to near 2,000 employees by the end of 2011.

This content is for Westfair Online members only. Please to view this content. Become a member by Registering Here. If you would prefer to start with a 12 week free trial, Click Here.

Non members are only allowed 10 clicks per month

Print Friendly, PDF & Email

Comments are closed.